JP2010535767A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535767A5
JP2010535767A5 JP2010519969A JP2010519969A JP2010535767A5 JP 2010535767 A5 JP2010535767 A5 JP 2010535767A5 JP 2010519969 A JP2010519969 A JP 2010519969A JP 2010519969 A JP2010519969 A JP 2010519969A JP 2010535767 A5 JP2010535767 A5 JP 2010535767A5
Authority
JP
Japan
Prior art keywords
dosage unit
vitamin
formulated
subject
hcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010519969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535767A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/009402 external-priority patent/WO2009035496A1/en
Publication of JP2010535767A publication Critical patent/JP2010535767A/ja
Publication of JP2010535767A5 publication Critical patent/JP2010535767A5/ja
Pending legal-status Critical Current

Links

JP2010519969A 2007-08-03 2008-08-04 栄養投与単位 Pending JP2010535767A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95393407P 2007-08-03 2007-08-03
US95394407P 2007-08-03 2007-08-03
PCT/US2008/009402 WO2009035496A1 (en) 2007-08-03 2008-08-04 Nutritional dosage unit

Publications (2)

Publication Number Publication Date
JP2010535767A JP2010535767A (ja) 2010-11-25
JP2010535767A5 true JP2010535767A5 (enExample) 2011-09-22

Family

ID=40341943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010519969A Pending JP2010535767A (ja) 2007-08-03 2008-08-04 栄養投与単位

Country Status (7)

Country Link
US (2) US20100143533A1 (enExample)
JP (1) JP2010535767A (enExample)
CN (1) CN101815509A (enExample)
CA (1) CA2695366C (enExample)
MX (1) MX2010001260A (enExample)
TW (1) TW200908892A (enExample)
WO (2) WO2009035496A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096564A2 (en) * 2009-02-19 2010-08-26 Probiohealth Llc Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits
US8853269B2 (en) * 2010-02-04 2014-10-07 Copperhead Chemical Company Inc. Composition and method for treating infections and promoting intestinal health
WO2011099031A1 (en) * 2010-02-11 2011-08-18 Zota Health Care Limited Active antioxidants for all age group
CN102630779B (zh) * 2011-02-14 2015-07-22 三得利食品饮料株式会社 配合槲皮素糖苷的容器装饮料
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
WO2015157428A1 (en) * 2014-04-08 2015-10-15 Mayo Foundation For Medical Education And Research Ingestible capsule
EP2962578A1 (en) * 2014-06-30 2016-01-06 Richard Hubertus Verheesen Method of providing a plurality of nutrition portions to a user and packaging product
EP3164145A4 (en) * 2014-07-01 2018-01-17 Probi Usa, Inc. Bi-layer dual release probiotic tablets
US20160073666A1 (en) * 2014-09-16 2016-03-17 New Chapter, Inc. Supplement for a Breastfeeding Woman
EP3242565A4 (en) * 2015-01-07 2018-06-27 Corr-Jensen Inc. Compositions and methods for enhancing athletic performance
EP3349735A4 (en) * 2015-09-16 2019-05-15 Corr-Jensen Inc. MULTI-PHASE RELEASE OF SPORTING NUTRITION AND ENERGY BEVERAGE COMPOSITIONS THROUGH LIPID PARTICLES
WO2017083549A1 (en) * 2015-11-10 2017-05-18 Probiotech Llc Probiotic delivery systems
US11291683B2 (en) * 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same
AU2017370929A1 (en) * 2016-12-09 2019-06-06 Balchem Corporation Essential nutrients and related methods
CN108836948B (zh) * 2018-06-11 2024-04-12 宁波西敦医药包衣科技有限公司 一种利用包衣技术实现营养素可控制释放的产品
US20190388344A1 (en) 2018-06-22 2019-12-26 Probiotech Llc Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
EP0208362A1 (en) * 1985-06-28 1987-01-14 The Procter & Gamble Company Dietary supplements containing iron and enterically coated calcium
NZ217821A (en) * 1985-10-10 1989-07-27 Biotech Australia Pty Ltd Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5445826A (en) * 1988-06-28 1995-08-29 Cibus Pharmaceutical, Inc. Delivery system containing a gel-forming dietary fiber and a drug
CH680263A5 (enExample) 1989-07-20 1992-07-31 Norman Godin
JPH05505935A (ja) * 1990-02-05 1993-09-02 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム ビタミン，ミネラルおよび他の有利な補給剤の徐放性処方
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
EP0662825B1 (en) * 1992-09-23 2003-03-19 Kv Pharmaceutical Corporation Multi-vitamin and mineral supplement for pregnant women
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
CA2199005A1 (en) * 1994-09-01 1996-03-07 Emile Bourland (Deceased) Compositions and methods for delivery of polypeptides
AU5252299A (en) * 1998-08-04 2000-02-28 Kv Pharmaceutical Company Multi-vitamin and mineral supplements for women
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6805880B1 (en) * 1999-08-20 2004-10-19 Ferrosan A/S Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress
GB0007419D0 (en) * 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
WO2002085415A1 (en) * 2001-04-17 2002-10-31 Biomatrix, Inc Non-digestible sugar-coated products and process
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
GB0403247D0 (en) * 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
US20060251722A1 (en) * 2005-05-03 2006-11-09 Novavax, Inc. Multi-component vitamin and mineral supplement for the optimal absorption of components
US20060270625A1 (en) * 2005-05-13 2006-11-30 Eastern Virginia Medical School Nutraceuticals for the treatment of neuropathy

Similar Documents

Publication Publication Date Title
JP2010535767A5 (enExample)
RU2018114447A (ru) Введение дейтерированных усилителей cftr
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
JP2012533565A5 (enExample)
HRP20121072T1 (hr) Postupci za davanje tetrahidrobiopterina, povezani pripravci i postupci mjerenja
JP2014198723A5 (enExample)
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson's disease
JP2014532704A5 (enExample)
JP2014001235A5 (enExample)
JP2010509326A5 (enExample)
MX352647B (es) Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.
BRPI0418681A (pt) um suplemento dietético para o tratamento e a prevenção de doenças do sistema digestivo e doenças relacionadas ao sistema digestivo e método de produção e administração deste
NZ625592A (en) Compositions and methods for the treatment of hepatic diseases and disorders
JP2014518274A5 (enExample)
JP2012236834A5 (enExample)
ME02474B (me) Terapijski režimi
JP2014221827A5 (enExample)
MX2013001637A (es) Composiciones farmaceuticas de liberacion controlada oral de blonanserina.
JP2011520980A5 (enExample)
JP2018039810A5 (enExample)
JP2007238598A5 (enExample)
PE20081895A1 (es) Regimen anticonceptivo oral
WO2011083402A3 (en) Immediate release compositions of acid labile drugs
JP2009505991A5 (enExample)